IGC Pharma (IGC) Operating Margin Growth (1y) (2011 - 2025)
IGC Pharma (IGC) Operating Margin Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.94 Bn | 132.09 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 86.59 Bn | 78.60 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 65.67 Bn | 60.49 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 57.81 Bn | 52.67 Bn | 52.00 Mn | 7,666.00 |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn | 1,238.00 |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn | 2,002.00 |
| 7 | BioNTech SE | 28.41 Bn | 10.02 Bn | 668.28 Mn | -3,558.00 |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 29,091.00 |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | -1,651.00 |
| 10 | IGC Pharma | 28.22 Mn | 27.96 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -109,062.00 |
| Jun 30, 2025 | 30,009.00 |
| Mar 31, 2025 | 30,741.00 |
| Dec 31, 2024 | 73,887.00 |
| Sep 30, 2024 | 42,883.00 |
| Jun 30, 2024 | -49,548.00 |
| Mar 31, 2024 | 169,754.00 |
| Dec 31, 2023 | -78,346.00 |
| Sep 30, 2023 | 37,567.00 |
| Jun 30, 2023 | 93,629.00 |
| Mar 31, 2023 | 289,556.00 |
| Dec 31, 2022 | 99,343.00 |
| Sep 30, 2022 | 653,260.00 |
| Jun 30, 2022 | 152,765.00 |
| Mar 31, 2022 | -188,301.00 |
| Dec 31, 2021 | 47,413.00 |
| Sep 30, 2021 | -642,349.00 |
| Jun 30, 2021 | -251,870.00 |
| Mar 31, 2021 | 497,846.00 |
| Dec 31, 2020 | -186,086.00 |